Nile Pharmaceuticals Reports 23% Slump in H1 Net Profit

By Yomna Yasser On Sep 7, 2014

Egypt-based Nile Pharmaceuticals and Chemical Industries published Sunday its first half results showing a decline in net profit by 23% year-on-year to register EGP 17 million.

In H1/13, the company (NIPH.CA on the Egyptian Exchange) posted a net profit of EGP 22.3 million.

H1 Net Profit industry & trade Nile Pharmaceuticals

Unified Licence to be Ready in Egypt by October – NTRA

Egypt’s EGX30 Hikes at Midday, Cross 9725 as Foreigners Buy